Zhang Jie, Yan Wenxiao, Dong Yansong, Luo Xinye, Miao Hua, Maimaijuma Talaibaike, Xu Xianggui, Jiang Haiyan, Huang Zhongwei, Qi Lei, Liang Guiwen
Department of Emergency Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China.
Department of Emergency Medicine, Rudong County People's Hospital, Nantong, China.
J Thorac Dis. 2024 Aug 31;16(8):5457-5476. doi: 10.21037/jtd-24-1191. Epub 2024 Aug 28.
Sepsis is a life-threatening organ dysfunction, and the most common and vulnerable organ is the lungs, with sepsis-related acute respiratory distress syndrome (ARDS) increasing mortality. In recent years, an increasing number of studies have improved our understanding of sepsis-related ARDS in terms of epidemiology, risk factors, pathophysiology, prognosis, and other aspects, as well as our ability to prevent, detect, and treat sepsis-related ARDS. However, sepsis-related lung injury remains an important issue and clinical burden. Therefore, a literature review was conducted on sepsis-related lung injury in order to further guide clinical practice in reducing the acute and chronic consequences of this condition.
This study conducted a search of the MEDLINE and PubMed databases, among others for literature published from 1991 to 2023 using the following keywords: definition of sepsis, acute lung injury, sepsis-related acute lung injury, epidemiology, risk factors, early diagnosis of sepsis-related acute lung injury, sepsis, ARDS, pathology and physiology, inflammatory imbalance caused by sepsis, congenital immune response, and treatment.
This review explored the risk factors of sepsis, sepsis-related ARDS, early screening and diagnosis, pathophysiology, and treatment and found that in view of the high mortality rate of ARDS associated with sepsis. In response to the high mortality rate of sepsis-related ARDS, some progress has been made, such as rapid identification of sepsis and effective antibiotic treatment, early fluid resuscitation, lung-protective ventilation, etc.
Sepsis remains a common and challenging critical illness to cure. In response to the high mortality rate of sepsis-related ARDS, progress has been made in rapid sepsis identification, effective antibiotic treatment, early fluid resuscitation, and lung-protective ventilation. However, further research is needed regarding long-term effects such as lung recruitment, prone ventilation, and the application of neuromuscular blocking agents and extracorporeal membrane oxygenation.
脓毒症是一种危及生命的器官功能障碍,最常见且最易受累的器官是肺,脓毒症相关急性呼吸窘迫综合征(ARDS)会增加死亡率。近年来,越来越多的研究增进了我们对脓毒症相关ARDS在流行病学、危险因素、病理生理学、预后及其他方面的理解,以及我们预防、检测和治疗脓毒症相关ARDS的能力。然而,脓毒症相关肺损伤仍然是一个重要问题和临床负担。因此,进行了一项关于脓毒症相关肺损伤的文献综述,以进一步指导临床实践,减少该病症的急性和慢性后果。
本研究在MEDLINE和PubMed等数据库中进行检索,以查找1991年至2023年发表的文献,使用了以下关键词:脓毒症的定义、急性肺损伤、脓毒症相关急性肺损伤、流行病学、危险因素、脓毒症相关急性肺损伤的早期诊断、脓毒症、ARDS、病理生理学、脓毒症引起的炎症失衡、先天性免疫反应和治疗。
本综述探讨了脓毒症、脓毒症相关ARDS的危险因素、早期筛查与诊断、病理生理学及治疗,发现鉴于与脓毒症相关的ARDS死亡率较高。针对脓毒症相关ARDS的高死亡率已取得了一些进展,如快速识别脓毒症和有效的抗生素治疗、早期液体复苏、肺保护性通气等。
脓毒症仍然是一种常见且难以治愈的危重病。针对脓毒症相关ARDS的高死亡率,在快速识别脓毒症、有效的抗生素治疗、早期液体复苏和肺保护性通气方面已取得进展。然而,对于肺复张、俯卧位通气以及神经肌肉阻滞剂和体外膜肺氧合的应用等长期影响,还需要进一步研究。